AAG
OSTX

Armstrong Advisory Group’s OS Therapies Inc OSTX Stock Holding History

Armstrong Advisory Group’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190 Hold
100
– – ﹤0.01% 970
2026
Q1 		$141 Hold
100
– – ﹤0.01% 944
2025
Q4 		$140 Hold
100
– – ﹤0.01% 942
2025
Q3 		$196 Hold
100
– – ﹤0.01% 928
2025
Q2 		$188 Hold
100
– – ﹤0.01% 916
2025
Q1 		$428 Hold
100
– – ﹤0.01% 825
2024
Q4 		$428 Hold
100
– – ﹤0.01% 825
2024
Q3 		$280 Buy
+100
New +$358 ﹤0.01% 772

Other funds holding OSTX

HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Armstrong Advisory Group's OSTX Position: Q2 2026 in Review

Armstrong Advisory Group held its OS Therapies Inc (OSTX) position steady in Q2 2026 at 100 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #970.

Armstrong Advisory Group first reported a position in OSTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $428 in Q1 2025. 8 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Armstrong Advisory Group held 100 shares of OS Therapies Inc worth $190 as of Q2 2026.
  • Armstrong Advisory Group left its OS Therapies Inc share count unchanged in Q2 2026.
  • OS Therapies Inc made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #970 holding.
  • Armstrong Advisory Group first reported a position in OS Therapies Inc in Q3 2024 and has held it in 8 quarters since.
  • Armstrong Advisory Group's OS Therapies Inc position peaked at $428 in Q1 2025.
  • 8 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.